Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  HIV Infection

  Free Subscription

Articles published in J Med Virol

Retrieve available abstracts of 79 articles:
HTML format

Single Articles

    September 2022
  1. SERWIN K, Scheibe K, Horecki M, Aksak-Was B, et al
    Detection of Polish cases of highly virulent subtype B of HIV-1 originating in the Netherlands.
    J Med Virol. 2022 Sep 15. doi: 10.1002/jmv.28154.
    PubMed     Abstract available

    August 2022
  2. GENG Y, Wang Y
    Stability and transmissibility of SARS-CoV-2 in the environment.
    J Med Virol. 2022 Aug 30. doi: 10.1002/jmv.28103.
    PubMed     Abstract available

  3. GHALEKHANI N, Bokaie S, Eybpoosh S, Akbarein H, et al
    Reconstruction of molecular evolution of human influenza A H1N1/2009 virus in Iran and neighboring countries.
    J Med Virol. 2022 Aug 24. doi: 10.1002/jmv.28090.
    PubMed     Abstract available

  4. KHELLAF L, Bouscarat F, Burrel S, Fidouh N, et al
    Novel mutations in antiviral multiresistant HSV-2 genital lesion: a case report.
    J Med Virol. 2022 Aug 16. doi: 10.1002/jmv.28070.
    PubMed     Abstract available

  5. JIANG X, Sharma PP, Rathi B, Ji X, et al
    Discovery of novel 1,2,4-triazole phenylalanine derivatives targeting an unexplored region within the interprotomer pocket of the HIV capsid protein.
    J Med Virol. 2022 Aug 10. doi: 10.1002/jmv.28064.
    PubMed     Abstract available

    July 2022
  6. RUPASINGHE D, Choi JY, Yunihastuti E, Kiertiburanakul S, et al
    Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia-Pacific.
    J Med Virol. 2022 Jul 22. doi: 10.1002/jmv.28019.
    PubMed     Abstract available

  7. LAN J, Li W, Yu R, Syed F, et al
    Cell-to-cell transmission of HIV-1 from provirus-activated cells to resting naive and memory human primary CD4 T cells is highly efficient and requires CD4 and F-actin but not chemokine receptors.
    J Med Virol. 2022 Jul 15. doi: 10.1002/jmv.28005.
    PubMed     Abstract available

    June 2022
  8. ZHU K, Xu Q, Ma Y, Li P, et al
    Suboptimal Immune Recovery and Associated Factors Among People Living with HIV/AIDS on Second-line Antiretroviral Therapy in Central China: A Retrospective Cohort Study.
    J Med Virol. 2022 Jun 16. doi: 10.1002/jmv.27944.
    PubMed     Abstract available

  9. AGUILAR G, Truong HM, Ovelar P, Samudio T, et al
    HIV Drug Resistance in Persons Initiating or Re-initiating First-line Antiretroviral Therapy in Paraguay: Results of a National Patient Survey.
    J Med Virol. 2022 Jun 14. doi: 10.1002/jmv.27933.
    PubMed     Abstract available

  10. BRAGAZZI NL, Kong JD, Mahroum N, Tsigalou C, et al
    Epidemiological trends and clinical features of the ongoing monkeypox epidemic: a preliminary pooled data analysis and literature review.
    J Med Virol. 2022 Jun 12. doi: 10.1002/jmv.27931.
    PubMed     Abstract available

  11. ASHURO AA, Zhang SC, Wang T, Chu QS, et al
    The Effect of protease inhibitors-based antiretroviral therapy on serum/plasma interleukin-6 levels among PLHIV: a systematic review and meta-analysis.
    J Med Virol. 2022 Jun 6. doi: 10.1002/jmv.27912.
    PubMed     Abstract available

  12. SAIED AA, Nascimento MSL, Rangel AHDN, Skowron K, et al
    Transchromosomic bovines (TcB)-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1 and Influenza A virus.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27907.
    PubMed     Abstract available

    May 2022
  13. BORGHETTI A, Farinacci D, Ciccullo A, Dusina A, et al
    Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir-rilpivirine in clinical practice.
    J Med Virol. 2022 May 31. doi: 10.1002/jmv.27890.
    PubMed     Abstract available

  14. FLEISCHER B, Olum R, Nakwagala FN, Nassozi DR, et al
    Higher intensive care unit consultations for COVID-19 patients living with HIV compared to those without HIV coinfection in Uganda.
    J Med Virol. 2022 May 26. doi: 10.1002/jmv.27887.
    PubMed     Abstract available

  15. CHU FL, Li C, Chen L, Dong B, et al
    Respiratory viruses among pediatric inpatients with acute lower respiratory tract infections in Jinan, China, 2016-2019.
    J Med Virol. 2022 May 20. doi: 10.1002/jmv.27875.
    PubMed     Abstract available

  16. CAI S, Liao G, Yu T, Gao Q, et al
    Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV: A cross-sectional study.
    J Med Virol. 2022 May 18. doi: 10.1002/jmv.27872.
    PubMed     Abstract available

  17. MALONGA GA, Dienta S, Traore FT, Maiga Z, et al
    Human Herpesvirus 8 seroprevalence among blood donors in Mali.
    J Med Virol. 2022 May 11. doi: 10.1002/jmv.27850.
    PubMed     Abstract available

  18. LALLOGO TD, Djigma FW, Sorgho PA, Martinson JJ, et al
    KIR2DL5B and HLA DRB1*12 alleles seems to be associated with protection against HIV-1 in serodiscordant couples in Burkina Faso.
    J Med Virol. 2022 May 2. doi: 10.1002/jmv.27821.
    PubMed     Abstract available

    April 2022
  19. LI Y, Wang X, Jin J, Ma Z, et al
    T cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.
    J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27814.
    PubMed     Abstract available

  20. YU H, Wu H, Subapriya R, Kaur A, et al
    Single-Center Experience on Progressive Multifocal Leukoencephalopathy (PML) cases, neuroimaging relevance, and management at West Virginia University (WVU).
    J Med Virol. 2022 Apr 21. doi: 10.1002/jmv.27804.
    PubMed     Abstract available

  21. ZHUANG K, Zhang Y, Mo P, Deng L, et al
    Plasma proteomic analysis reveals altered protein abundances in HIV-infected patients with or without Non-Hodgkin Lymphoma.
    J Med Virol. 2022 Apr 12. doi: 10.1002/jmv.27775.
    PubMed     Abstract available

  22. MEHRAEEN E, SeyedAlinaghi S, Karimi A
    The Post-Omicron Situation: The End of the Pandemic or a Bigger Challenge?
    J Med Virol. 2022 Apr 6. doi: 10.1002/jmv.27765.
    PubMed     Abstract available

    March 2022
  23. FIORE BD, Andrea V, Giuseppe P, Yagai B, et al
    Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study.
    J Med Virol. 2022 Mar 31. doi: 10.1002/jmv.27754.
    PubMed     Abstract available

  24. HUANG J, Wu H, Lin S, Lu L, et al
    Spatial-temporal analysis of HIV/AIDS and syphilis in mainland China from 2007 to 2017.
    J Med Virol. 2022 Mar 16. doi: 10.1002/jmv.27725.
    PubMed     Abstract available

  25. WILLIAMS ME, Ruhanya V, Paul RH, Ipser JC, et al
    An investigation of the HIV Tat C31S and R57S mutation on peripheral immune marker levels in South African participants: A pilot study.
    J Med Virol. 2022 Mar 13. doi: 10.1002/jmv.27720.

  26. GIOVANETTI M, Farcomeni S, Sernicola L, Virtuoso S, et al
    Analysis of HIV-1 integrase genotypes and polymorphisms among integrase inhibitors-based antiretroviral treatment naive patients in South Sudan.
    J Med Virol. 2022 Mar 11. doi: 10.1002/jmv.27713.
    PubMed     Abstract available

  27. SU B, Kong D, Yang X, Zhang T, et al
    Mucosal-associated invariant T cells: a cryptic coordinator in HIV-infected immune reconstitution.
    J Med Virol. 2022 Mar 3. doi: 10.1002/jmv.27696.
    PubMed     Abstract available

    February 2022
  28. MARAIS G, Naidoo M, McMullen K, Stanley A, et al
    Varicella-zoster virus reactivation is frequently detected in HIV-infected individuals presenting with stroke.
    J Med Virol. 2022 Feb 8. doi: 10.1002/jmv.27651.
    PubMed     Abstract available

  29. SHAHZAD M, Chen H, Akhtar T, Rafi A, et al
    Human Immunodeficiency Virus: The potential of medicinal plants as anti-retroviral therapy.
    J Med Virol. 2022 Feb 6. doi: 10.1002/jmv.27648.
    PubMed     Abstract available

  30. MILANO E, Ricciardi A, Casciaro R, Pallara E, et al
    Immunogenicity and safety of the BNT162b2 COVID-19 mRNA vaccine in PLWH: a monocentric study in Bari, Italy.
    J Med Virol. 2022 Feb 1. doi: 10.1002/jmv.27629.
    PubMed     Abstract available

    January 2022
  31. COUTLEE F, de Pokomandy A, Burchell AN, El-Zein M, et al
    Human papillomavirus genotype concordance between Anyplex II HPV28 and linear array HPV genotyping test in anogenital samples.
    J Med Virol. 2022 Jan 20. doi: 10.1002/jmv.27605.
    PubMed     Abstract available

  32. ZHANG X, Fang Q, Zhu S, Wu X, et al
    Environmental risk factors and genetic markers of Kaposi's sarcoma-associated herpesvirus infection among Uygur population in Xinjiang, China.
    J Med Virol. 2022 Jan 18. doi: 10.1002/jmv.27600.
    PubMed     Abstract available

  33. LI T, Cui Z, Jia Y, Liang Z, et al
    Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift.
    J Med Virol. 2022 Jan 14. doi: 10.1002/jmv.27596.
    PubMed     Abstract available

  34. KURY CMH, Guimaraes GR, Leandro CG, Fernandes LA, et al
    Associations of human papillomavirus (HPV) genotypes and related risk factors in a cohort of women living with HIV in a Brazilian countryside city.
    J Med Virol. 2022 Jan 9. doi: 10.1002/jmv.27582.
    PubMed     Abstract available

  35. AKEKAWATCHAI C, Phuegsilp C, Changsri K, Soimanee T, et al
    Distribution of +874T/A IFN-gamma and -509C/T TGF-beta1 Single Nucleotide Polymorphisms in Human Immunodeficiency Virus-infected Thais.
    J Med Virol. 2022 Jan 4. doi: 10.1002/jmv.27567.
    PubMed     Abstract available

  36. MOUSAVI SH, Qaderi S, Ahmadi A, Arman SI, et al
    The daunting task of fighting HIV in Afghanistan: Current evidence and future recommendationsThe daunting task of fighting HIV in Afghanistan: Current evidence and future recommendations.
    J Med Virol. 2022 Jan 3. doi: 10.1002/jmv.27566.
    PubMed     Abstract available

  37. ADACHI E, Saito M, Nagai H, Ikeuchi K, et al
    Transient depletion of T cells during COVID-19 and seasonal influenza in people living with HIV.
    J Med Virol. 2022 Jan 2. doi: 10.1002/jmv.27543.
    PubMed     Abstract available

    December 2021
  38. DENG H, Feng Q, Wu Y, Lin H, et al
    Immune response to hepatitis B vaccination in human immunodeficiency virus-positive patients in China: A 2-year retrospective study.
    J Med Virol. 2021 Dec 14. doi: 10.1002/jmv.27523.
    PubMed     Abstract available

  39. BORSETTI A, Scarpa F, Maruotti A, Divino F, et al
    The unresolved question on COVID-19 virus origin: The three cards game?
    J Med Virol. 2021 Dec 12. doi: 10.1002/jmv.27519.
    PubMed     Abstract available

    October 2021
  40. CHAVAN VR, Ahir S, Kerkar S, Ansari Z, et al
    Th1 cytokine gene polymorphism and the corresponding plasma cytokine levels: A comparative study in HIV-1 positive and exposed uninfected infants.
    J Med Virol. 2021 Oct 26. doi: 10.1002/jmv.27408.
    PubMed     Abstract available

  41. MATSUDA EM, Ahagon CM, Coelho LPO, Campos IB, et al
    A simple algorithm for selecting cases to investigate acute and early HIV infections in low- and middle-income countries.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27398.
    PubMed     Abstract available

  42. RAHMAN S, Sarker MS, Aralaguppe SG, Sarwar G, et al
    Drug resistance pattern among ART-naive clients attending an HIV testing and counseling center in Dhaka, Bangladesh.
    J Med Virol. 2021 Oct 12. doi: 10.1002/jmv.27387.
    PubMed     Abstract available

    August 2021
  43. HASAN MM, Mohanan P, Emmanuella N, Costa ACDS, et al
    Challenges of HIV amidst COVID-19 in Africa: Can we conquer them?
    J Med Virol. 2021 Aug 17. doi: 10.1002/jmv.27276.
    PubMed     Abstract available

  44. ZHOU R, Liu L, Wang Y
    Viral Proteins Recognized by Different TLRs.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27265.
    PubMed     Abstract available

  45. COUSIN E, Belicard F, Michel L, Pronier C, et al
    Severe cytomegalovirus disease with encephalitis after CAR-T cell therapy: a rare but potentially fatal complication.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27257.
    PubMed     Abstract available

    July 2021
  46. PEREIRA-VAZ J, Crespo P, Mocho L, Martinho P, et al
    Identification of a new 2-amino acid insertion in the integrase coding region of HIV-1 subtype G isolates.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27205.
    PubMed     Abstract available

    June 2021
  47. ULLAH I, Hassan W, Tahir MJ, Ahmed A, et al
    Antiretrovirals shortage in Kenya amid COVID-19.
    J Med Virol. 2021 Jun 18. doi: 10.1002/jmv.27134.

  48. SILVA DMD, Goncales JP, Silva Junior JVJ, Lopes TRR, et al
    Evaluation of IL-2, IL-4, IL-6, IL-10, TNF-alpha, and IFN-gamma cytokines in HIV/HHV-8 coinfection.
    J Med Virol. 2021;93:4033-4037.
    PubMed     Abstract available

  49. LU J, Jia J, Zhang J, Liu X, et al
    HIV p17 enhances T cell proliferation by suppressing autophagy through the p17-OLA1-GSK3beta axis under nutrient starvation.
    J Med Virol. 2021;93:3607-3620.
    PubMed     Abstract available

  50. DAI L, Jung BG, Chen J, Samten B, et al
    The potential impacts of early secreted antigenic target of 6 kDa of Mycobacterium tuberculosis on KSHV-infected cells.
    J Med Virol. 2021;93:4028-4032.
    PubMed     Abstract available

  51. DA SILVA PRATES G, Malta FM, de Toledo Goncalves F, Monteiro MA, et al
    AIDS incidence and survival in a hospital-based cohort of HIV-positive patients from Sao Paulo, Brazil: The role of IFN-lambda4 polymorphisms.
    J Med Virol. 2021;93:3601-3606.
    PubMed     Abstract available

    May 2021
  52. TING Y, Liang S, Yang S, Lin Y, et al
    Phylogenetic characteristics of HIV among female cross-border travelers in Yunnan Province between 2003 and 2012.
    J Med Virol. 2021 May 11. doi: 10.1002/jmv.27079.
    PubMed     Abstract available

    April 2021
  53. SANTINELLI L, De Girolamo G, Borrazzo C, Vassalini P, et al
    Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27028.
    PubMed     Abstract available

  54. PATEL UK, Malik P, Li Y, Habib A, et al
    Stroke and HIV-Associated Neurological Complications: A Retrospective Nationwide Study.
    J Med Virol. 2021 Apr 10. doi: 10.1002/jmv.27010.
    PubMed     Abstract available

  55. BULFONI M, Pravisani R, Dalla E, Cesselli D, et al
    miRNA expression profiles in liver grafts of HCV and HIV/HCV infected recipients, six months after liver transplantation.
    J Med Virol. 2021 Apr 5. doi: 10.1002/jmv.26999.
    PubMed     Abstract available

    March 2021
  56. ARRAIS CRA, Lima K, Barreiros M, Rodrigues JKF, et al
    HIV-1 Subtypes and Drug Resistance in Children During Antiretroviral Therapy in Brazil.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26988.
    PubMed     Abstract available

  57. WU Y, Yang Y, Wei H, Jia L, et al
    Mortality Predictors among Patients with HIV-Associated Pulmonary Tuberculosis in Northeast China: A Retrospective Cohort Analysis.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26977.
    PubMed     Abstract available

    February 2021
  58. OLUSOLA BA, Olaleye DO, Odaibo GN
    New Infections and HIV-1 Subtypes Among Febrile Persons and Blood Donors in Oyo State, Nigeria.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26872.
    PubMed     Abstract available

  59. ROJAS-BOLIVAR D, Intimayta-Escalante C, Cardenas-Jara A, Jandarov R, et al
    COVID-19 case fatality rate and tuberculosis in a metropolitan setting.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26868.
    PubMed     Abstract available

    January 2021
  60. NASREDDINE R, Florence E, Moutschen M, Yombi JC, et al
    Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26828.
    PubMed     Abstract available

  61. O'ROURKE S, O'Flaherty N, Coyne D, Lynam A, et al
    Seroprevalence of human herpesvirus 8 in Ireland among blood donors, men who have sex with men and heterosexual Genitourinary Medicine and Infectious Diseases clinic attendees.
    J Med Virol. 2021 Jan 21. doi: 10.1002/jmv.26813.
    PubMed     Abstract available

  62. HUANG XH, Yu G, Zheng C, Zhou PP, et al
    Genomic characterization of a new CRF01_AE/CRF07_BC case from a MSM patient in Guangdong, China.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26799.
    PubMed     Abstract available

    December 2020
  63. DUBEY RC, Alam NB, Gaur R
    miR-150-mediated increase in glucose uptake in HIV-infected cells.
    J Med Virol. 2020 Dec 24. doi: 10.1002/jmv.26755.
    PubMed     Abstract available

  64. SARKAR S, Khanna P, Singh AK
    Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26740.
    PubMed     Abstract available

  65. ANNAMALAY AA, Abbott S, Khoo SK, Hibbert J, et al
    The Impact of Cytokine Levels in Young South African Children with and without HIV-associated Acute Lower Respiratory Infections.
    J Med Virol. 2020 Dec 14. doi: 10.1002/jmv.26730.
    PubMed     Abstract available

  66. LATHOUWERS E, Weinsteiger S, Baugh B, Ghys A, et al
    Week 96 resistance analyses of the once-daily, Single-tablet Regimen (STR) Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in adults living with HIV-1 from the phase 3 randomized AMBER and EMERALD trials.
    J Med Virol. 2020 Dec 10. doi: 10.1002/jmv.26721.
    PubMed     Abstract available

  67. WAN T, Liu X, Su Y, Zou J, et al
    Biological Differentiation of Traditional Chinese Medicine from Excessive to Deficient Syndromes in AIDS: Comparative MicroRNA Microarray Profiling and Syndrome-Specific Biomarker Identification.
    J Med Virol. 2020 Dec 2. doi: 10.1002/jmv.26704.
    PubMed     Abstract available

    November 2020
  68. SWAMINATHAN N, Moussa P, Mody N, Bryan Lo K, et al
    COVID-19 in HIV infected patients: A Case series and Literature Review.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26671.
    PubMed     Abstract available

  69. ZENG J, Zhang X, Jia L, Wu Y, et al
    Pretreatment Lymphocyte-to-Monocyte Ratios Predict AIDS-related Diffuse Large B-Cell Lymphoma Overall Survival.
    J Med Virol. 2020 Nov 6. doi: 10.1002/jmv.26655.
    PubMed     Abstract available

    October 2020
  70. TEKIN D, Gokengin D, Onay H, Erensoy S, et al
    Investigation of Drug Resistance Against Protease, Reverse Transcriptase and Integrase Inhibitors by Next Generation Sequencing in HIV Positive Patients.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26582.
    PubMed     Abstract available

  71. CAKIR B
    The outcome of COVID-19 in patients with hematological malignancy.
    J Med Virol. 2020 Oct 2. doi: 10.1002/jmv.26576.
    PubMed     Abstract available

    September 2020
  72. LY HI, Kelly M, Fall MVM, Fall-Malick FZ, et al
    Prevalence of therapeutic failure and evolution of biological factors amongst people living with HIV enrolled in anti-retroviral therapy at the Ambulatory Treatment Center in Nouakchott, Mauritania.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26562.
    PubMed     Abstract available

  73. MONDI A, Cimini E, Colavita F, Cicalini S, et al
    COVID-19 in people living with HIV: clinical implications of dynamics of immune response to SARS-CoV-2.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26556.
    PubMed     Abstract available

  74. NAGARAKANTI SR, Okoh AK, Grinberg S, Bishburg E, et al
    Clinical outcomes of patients with COVID-19 and HIV coinfection.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26533.
    PubMed     Abstract available

    August 2020
  75. PATRA R, Chandra Das N, Mukherjee S
    Targeting human TLRs to combat COVID-19: A solution?
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26387.
    PubMed     Abstract available

    July 2020
  76. RAMASWAMY M, Bruden D, Nolen LD, Mosites E, et al
    Hepatitis A vaccine immunogenicity 25 years after vaccination in Alaska.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26327.
    PubMed     Abstract available

  77. PRZYDZIAL P, Tchomobe G, Amin K, Christian E, et al
    When COVID-19 Crosses Paths with AIDS in the Homeless.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26255.
    PubMed     Abstract available

    April 2020
  78. CURE E, Cumhur Cure M
    Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19".
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25848.
    PubMed     Abstract available

    March 2020
  79. OH JJ, Carter JJ, Nemeno JGE, Dix RD, et al
    Parthanatos-associated proteins are stimulated intraocularly during development of experimental murine cytomegalovirus retinitis in mice with retrovirus-induced immunosuppression.
    J Med Virol. 2020;92:394-398.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.